Arcutis Biotherapeutics, Inc.
Nasdaq ARQT · Westlake Village, CA
Works in Dermatology · Genetic & rare · Immunology
Arcutis Biotherapeutics, Inc. is a clinical trial sponsor based in Westlake Village, CA, listed as Nasdaq ARQT. It has 1 active clinical trial with 125 planned participants, in Dermatology, Genetic & rare and Immunology. Since 2021 it has completed 23 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq ARQT
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about Arcutis Biotherapeutics, Inc
Arcutis Biotherapeutics, Inc is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 125 planned participants, in Dermatology, Genetic & rare, Immunology. Since 2021 it has completed 23 trials and stopped 1 early.
Arcutis Biotherapeutics, Inc is based in Westlake Village, CA and is listed as Nasdaq ARQT. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Arcutis Biotherapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-05.
Approve Suite is not affiliated with Arcutis Biotherapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.